Tirozol

Quick links to important sections

Tirozol

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tirozol

What is Tirozol? (Overview)

Property Description
Active Ingredient Thiamazole (or Methimazole)
Form Oral, Film-Coated Tablet
Pharmacological Class Antithyroid Agent / Thionamide
Common Purpose Reduces thyroid hormone overproduction
Origin Synthetic (chemically manufactured)

What Type of Medicine is Tirozol?

Tirozol is a prescription-only medicine containing the active ingredient Thiamazole, which is clinically recognized as a primary Antithyroid Agent for managing hyperthyroidism. It belongs to the thionamide pharmacological class, a group of drugs that addresses the core problem of an overactive thyroid gland. The ingredient, Thiamazole, is also widely known as methimazole in international settings. The drug is classified as a synthetic organic compound.


Distinctive Features and Composition

Tirozol is supplied as an oral, film-coated tablet, which is one of the most common and convenient forms for long-term thyroid management. This brand is a single-ingredient drug containing only Thiamazole. The film coating is a feature designed to improve the tablet’s stability and ease of swallowing, ensuring precise dosage via the oral route of administration. Thiamazole is a well-established substance for controlling excessive thyroid activity in patients.


What is the General Purpose of Tirozol?

The general purpose of Tirozol is to normalize the body’s metabolism by slowing the excessive production of thyroid hormones. This medicine helps patients reach and maintain a stable euthyroid state—a medically normal level of thyroid function—which is the goal for managing hyperthyroidism. It achieves this by acting as a synthesis inhibitor, preventing the thyroid gland from overworking.

Regulatory References

  1. Thiamazole DailyMed Label

What side effects are possible with Tirozol?

Possible Side Effects and Safety Information

The safety profile of Tirozol (Thiamazole) is officially documented by regulatory agencies and classifies adverse reactions based on their observed frequency. The most frequently reported effects are generally Very Common or Common and involve the Skin and Subcutaneous Tissue and Musculoskeletal Systems.


Frequency Classification Examples (Organ Systems)
Very Common Skin reactions (e.g., pruritus, rash, urticaria)
Common Arthralgia (joint pain), mild gastrointestinal disturbances
Uncommon Agranulocytosis

Serious Adverse Reactions

The official labeling identifies certain serious, though rare, safety risks. These include Agranulocytosis, a severe blood disorder most frequently observed within the first few months of treatment. Other very rare but significant risks involve the Hepatobiliary System, such as Severe Hepatic Failure or cholestatic jaundice, and Systemic Lupus Erythematosus (SLE)-like syndrome.

Population-Specific Safety Notes

The medicine is contraindicated in individuals with a known hypersensitivity to thionamides or those with severe blood disorders or pre-existing severe hepatic impairment. Furthermore, official safety statements note specific risks during pregnancy, particularly concerning congenital malformations when administered during the first trimester. Due to the risks of agranulocytosis and hepatotoxicity, labels indicate that blood cell counts and liver function tests warrant monitoring.

These classifications and constraints define the structured risk profile of the medicine according to government regulatory standards.

Overdose and Emergency Response

The official prescribing information for Tirozol (Thiamazole/Methimazole) outlines specific manifestations that may occur in an overdose scenario. Documented acute symptoms include nausea, vomiting, epigastric distress, headache, fever, joint pain (arthralgia), pruritus, and edema.

Of greater concern are the potential for severe, life-threatening outcomes affecting major body systems. Regulatory documents cite the possibility of rapidly manifesting aplastic anemia (pancytopenia) or agranulocytosis in the hours to days following the event. Less frequent but documented severe effects include hepatitis, nephrotic syndrome, exfoliative dermatitis, and central nervous system effects like neuropathies or CNS stimulation/depression.

Immediate action is required in the event of suspected overdose. The official regulatory instruction is to contact a Poison Control Center or Emergency Room at once. Treatment of overdose is strictly symptomatic and supportive, as no specific antidote is known or listed in the regulatory documents. Management involves monitoring the patient's medical status, which may include assessment of vital signs, blood gases, serum electrolytes, and potentially bone marrow function. There are no population-specific overdose management instructions listed beyond this general supportive care principle.

Therapeutic Uses of Tirozol

Main Uses of Tirozol

Tirozol is an antithyroid medication containing the active substance thiamazole (also known as methimazole). It is primarily used to manage conditions characterized by an overactive thyroid gland, a state known as hyperthyroidism.

Management of Hyperthyroidism

The primary function of Tirozol is to inhibit the overproduction of thyroid hormones. By reducing the synthesis of these hormones within the thyroid gland, the medication helps restore metabolic balance. This application is central to treating several underlying causes of thyroid overactivity:

  • Graves' Disease: An autoimmune disorder and the most common cause of hyperthyroidism, where the body's immune system stimulates the thyroid to produce excessive hormones.
  • Toxic Adenoma and Multinodular Goiter: Conditions where one or more nodules develop in the thyroid gland and produce thyroid hormones independently of the body's normal regulatory system.

Preoperative and Pre-treatment Stabilization

Tirozol is frequently used as a preparatory treatment to stabilize thyroid hormone levels before other medical interventions. Achieving a euthyroid state (normal thyroid function) is often necessary in the following scenarios:

  • Preparation for Thyroid Surgery: Normalizing hormone levels before a thyroidectomy (surgical removal of the thyroid) reduces the risk of complications during and after the procedure.
  • Radioactive Iodine Treatment: The medication may be used to control symptoms and hormone levels in the period leading up to radioiodine therapy.

Benefits in Clinical Management

By regulating the output of thyroid hormones, Tirozol assists in alleviating the physiological strain caused by hyperthyroidism. The benefits of this stabilization include:

  • Symptomatic Relief: Reducing hormone levels helps mitigate common symptoms of an overactive metabolism, such as rapid heartbeat, excessive sweating, tremors, and weight loss.
  • Prevention of Complications: Long-term control of hyperthyroidism is essential for protecting cardiovascular health and bone density, which can be negatively impacted by prolonged exposure to high levels of thyroid hormones.
  • Therapeutic Flexibility: It can be used for long-term maintenance therapy or as a short-term measure to bridge patients toward definitive treatments.

Eligibility and Restrictions for Use

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Adults with hyperthyroidism. Use is established in children and adolescents (generally ages 3 and up).
Populations for whom use is contraindicated Patients with known hypersensitivity to thiamazole or product components. History of acute pancreatitis after prior methimazole or carbimazole use.
Eligibility-related restrictions Use must be discontinued in the presence of agranulocytosis, aplastic anemia (pancytopenia), or severe hepatic abnormality (transaminases > 3x ULN).
Age-related eligibility rules Not recommended for children 2 years of age and under; efficacy and safety are not systematically evaluated in this group.
Pregnancy and lactation eligibility status Pregnant women in the first trimester are restricted; use requires a strict individual benefit/risk assessment at the lowest effective dose. Use is generally contraindicated in breastfeeding women by some national authorities.

Eligibility Classifications (High-Level)

Category Official Regulatory Classification/Statement
Eligibility severity classification Classified as Contraindicated (e.g., Hypersensitivity), Not Recommended (e.g., First Trimester Pregnancy), or Established Use (e.g., Adults).
Eligibility-context constraints Patients with renal impairment should use with caution. Use in women of childbearing potential mandates effective contraceptive measures during therapy.

Connection to the overall eligibility profile

Regulatory documents define who can and cannot use Tirozol by establishing absolute contraindications based on hypersensitivity and specific severe pre-existing conditions. Restricted eligibility applies to populations such as pregnant women and those with impaired organ function, requiring use only after formal benefit/risk assessment and close surveillance. These classifications formally dictate the authorized boundaries for the medicine's use.

What should I know about interactions with other medicines?

Tirozol (Thiamazole) has officially documented interaction patterns primarily governed by status-dependent clearance changes and specific metabolic and procedural restrictions.

Formal Restrictions and Contraindications

Co-administration with Eliglustat is formally contraindicated because Thiamazole affects CYP2D6 metabolism, resulting in significantly increased Eliglustat plasma exposure. For procedural reasons, Thiamazole must be discontinued for at least three to four days prior to the administration of Sodium Iodide I-131 (Radioactive Iodine) to prevent reduced therapeutic effectiveness. Tirozol may also increase the exposure of Lonafarnib through an effect on CYP3A4 metabolism.


Status-Dependent and Pharmacodynamic Interactions

The documented interactions with several other medicines are linked to the transition of the patient from a hyperthyroid state to a stable euthyroid state. This change in thyroid status can lead to a decrease in drug clearance for medicines such as Beta-Adrenergic Blocking Agents, Digitalis Glycosides, and Theophylline. This reduction in clearance can result in increased serum levels or exposure to these co-administered products.

Regulatory documents also define pharmacodynamic risks: the activity of Oral Anticoagulants may be potentiated due to an officially documented anti-vitamin K effect. Furthermore, co-administration with other Myelosuppressive Agents increases the risk of agranulocytosis through a pharmacodynamic additive effect.

Mechanism of Action

The core mechanism of Tirozol is its specific intervention in the thyroid hormone synthesis pathway. The active ingredient, Thiamazole, acts as an effective inhibitor of the enzyme Thyroid Peroxidase (TPO), which is essential for hormone production inside the thyroid gland. By acting as a competitive substrate, the drug blocks two critical chemical steps: the iodination of tyrosine residues and the subsequent coupling of these iodotyrosines to form the active hormones, Thyroxine (T4) and Triiodothyronine (T3). This mechanism directly arrests the de novo creation of new hormone molecules, causing modulation of metabolic regulatory signaling.


The cessation of new hormone synthesis leads to the progressive systemic depletion of thyroid hormones. The drug's mechanism does not affect the large pool of T4 and T3 already stored in the thyroid gland's colloid or circulating in the bloodstream. Consequently, the resulting physiological effect is entirely dependent upon the body's natural metabolic processes clearing these existing reserves over time. This mechanism limitation dictates the time-to-effect profile, resulting in the gradual normalization of the basal metabolic rate as circulating hormone concentrations decrease.

Dosage and Administration Information

How to Use Tirozol (Thiamazole): Official Administration Guidelines

Tirozol, containing the active ingredient Thiamazole, is administered exclusively via the oral route as a film-coated tablet. The official administration protocol is structured into two main phases: an initial therapy to gain control and a long-term maintenance phase. The tablets should be swallowed whole with sufficient liquid and may be taken with or without food.


Official Dosing and Scheduling Patterns

The total daily dose is determined by the severity of the condition. For adults, initial daily dosages typically range from 15 mg to 60 mg. During this initial phase, the total amount is usually administered in three divided doses daily at regular intervals. Following clinical improvement, usually after four to eight weeks, the dosage is titrated down to a lower maintenance range, typically 5 mg to 15 mg daily, which may then be administered as a single daily dose.


Population and Procedural Rules

Instruction Detail
Pediatric Dosing Initial daily dosing is based on body weight (0.4 mg/kg), divided into three doses.
Hepatic Impairment The dosage must be kept as low as possible to account for reduced clearance.
Missed Dose Do not take a double dose. If the time for the next dose is near, the missed dose should be skipped.

Duration of Use: The conservative course of treatment typically lasts 6 months to 2 years.

Recent Clinical Evidence

Tirozol: Recent Clinical Evidence

Summary of Key Findings

Research investigated the compound (Thiamazole/Methimazole) for its role in the management of hyperthyroidism, a condition characterized by excessive thyroid hormone production. Studies explored the agent's ability to interfere with thyroid hormone synthesis. The compound is primarily evaluated for long-term suppressive therapy, as preoperative preparation, and in specific cases where other treatments are not suitable.

Researchers examined the compound's effect on thyroid peroxidase, a key enzyme involved in hormone production. Study documentation recorded the tolerability of the agent among most participants. Post-marketing surveillance and epidemiological studies have noted specific safety updates, including a reported risk of acute pancreatitis and an updated risk profile regarding congenital malformations, particularly when administered during the first trimester of pregnancy.

Evidence on Research Focus and Findings

Mechanism of Action

Clinical data consistently show that the agent works by inhibiting the thyroid peroxidase enzyme, which is essential for the iodination of tyrosine residues within thyroglobulin, ultimately reducing the formation of the hormones T4 and T3. This action is the basis for its therapeutic use in restoring normal thyroid function.

Combination and Long-Term Therapy

Clinical trials have assessed the agent's use in combination with levothyroxine, primarily in patients with hyperthyroidism and a large goiter to manage the risk of further thyroid growth. Research also examines the compound's role prior to radioactive iodine therapy, where it may reduce the biological half-life of iodine in the thyroid tissue. Evidence supports the use of the drug for conservative treatment regimens ranging from six months to two years, focusing on sustaining normal thyroid activity.

Key Studies & References

  1. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
  2. Methimazole - StatPearls - NCBI Bookshelf
  3. Birth Defects From Antithyroid Drugs (Focus on Methimazole embryopathy)

Frequently Asked Questions (FAQ)

Common questions about Tirozol (FAQ)

Q: Is Tirozol a permanent solution for hyperthyroidism?

Official information indicates that the goal of treatment is often to achieve remission, which is a return to normal thyroid function without needing the drug. The treatment course is typically limited in duration. Unlike definitive treatments such as surgery or radioactive iodine, the medicine itself is not designed to permanently destroy thyroid function.

Q: What is the typical time frame before a patient begins to feel the effects of Tirozol?

The medicine works by stopping the creation of new thyroid hormones, but it does not affect hormones already stored in the body. Because of this mechanism, official sources indicate that the full therapeutic effects, including symptom relief, may take a few weeks to become fully apparent as existing hormone reserves are cleared.

Q: Is there a generic version of the medicine that is the same as the brand name Tirozol?

Yes, the active ingredient, Thiamazole, is also widely known by the generic name Methimazole. This ingredient is available as a generic medication. Regulatory standards mandate that generic versions must meet the same quality and effectiveness requirements as the brand-name product.

Q: Why is Tirozol sometimes prescribed for patients with Graves' disease?

Regulatory documents formally indicate this medication for the treatment of hyperthyroidism, which is the overactive thyroid state. This includes its use in patients diagnosed with Graves' disease, which is the most common cause of hyperthyroidism, and for those with toxic multinodular goiter.

Q: What is the difference between how Tirozol works and how radioactive iodine works?

Tirozol is an antithyroid drug that works by blocking the synthesis of new thyroid hormones. In contrast, treatments like radioactive iodine are considered definitive therapies. These treatments physically destroy the overactive thyroid gland tissue to permanently stop its function.

Q: What general expectations should patients have about symptom improvement with Tirozol?

Symptom improvement is expected to occur gradually over the course of treatment. This is linked to the medicine's slow action of normalizing the basal metabolic rate. As hormone levels decrease, patients may notice the amelioration of symptoms associated with hyperthyroidism.

Q: How does Tirozol compare to other antithyroid medicines, generally?

This medication belongs to the thionamide pharmacological class. In clinical guidelines, it is often described as a first-line antithyroid agent for most adults. Authoritative sources note that this classification is often related to the medication’s established profile when compared to other similar antithyroid agents.

Q: Does Tirozol interact with common over-the-counter pain relievers?

Official safety warnings highlight the risk of rare but serious liver toxicity associated with this medication. Therefore, caution is generally advised when combining it with any other substance, including over-the-counter pain relievers, that also poses a known risk to liver function.

Q: Can individuals with a history of heart conditions use Tirozol?

Authoritative clinical recommendations emphasize the need for close medical monitoring when this medicine is used in individuals with pre-existing heart conditions. This monitoring is required because changes in thyroid function can influence other body systems, including the heart.

Q: Is Tirozol known to cause any changes in weight?

Since a potential risk of the medication is causing an underactive thyroid (hypothyroidism), and hypothyroidism is associated with weight changes, routine monitoring of thyroid hormone levels is necessary. These hormonal changes are the factor that may influence weight.

Q: Is it safe to consume alcohol while undergoing treatment with Tirozol?

General drug safety warnings advise against consuming alcohol while taking this medication. This guidance is in place because both substances carry a known, independent risk of potential liver damage.

Q: What are the chances of a person needing a second course of Tirozol treatment?

Official clinical data indicate that recurrence of hyperthyroidism after stopping antithyroid drugs is a known issue. Studies estimate significant relapse rates for Graves' disease, which may prompt the need for a possible second course or referral to a definitive therapy.

Q: Is Tirozol considered a first-line treatment for hyperthyroidism in general guidelines?

Yes, authoritative clinical guidelines typically classify this medicine as a first-line antithyroid agent for most adults. This designation is based on its established profile when compared to other similar medications.

Q: Does Tirozol treatment always require subsequent thyroid hormone replacement?

The medication can cause an underactive thyroid (hypothyroidism), which would then require hormone replacement to treat. Hormone replacement is also sometimes intentionally used as part of a specific clinical approach known as 'block-and-replace' therapy.

Q: Can Tirozol cause or worsen hair thinning?

Official patient information indicates that hair loss or thinning is listed as a potential adverse reaction to the medication.

Q: Does Tirozol affect fertility in males or females?

Regulatory documents cite animal studies that have examined a potential for impairment of fertility. However, the official documentation states that the clinical significance of these findings in humans remains unclear.

Q: Are there any specific concerns for elderly patients using Tirozol?

Older patients often require particularly close monitoring during treatment, according to authoritative clinical recommendations. This heightened surveillance is due to the increased likelihood of co-existing conditions, especially those affecting the heart and central nervous system.

Q: Is feeling tired a common initial reaction to starting Tirozol treatment?

Official patient information lists general fatigue or feeling sleepy as a potential side effect associated with taking the medication.

Q: Does Tirozol have any known interactions with herbal supplements?

Regulatory and authoritative sources indicate a general lack of formal testing and information concerning interactions with herbal remedies. Regulatory sources note that consulting a healthcare provider before taking supplements is consistent with safe practice, due to the potential for some substances to affect thyroid function test results.

Q: Is there a rebound effect if Tirozol treatment is stopped?

Clinical data indicates that patients who discontinue the medication for Graves' disease are at risk of relapse, which is a return of hyperthyroidism. Patients are monitored for this possibility after stopping treatment.

Q: Can Tirozol be used by people who have other autoimmune conditions?

Official documentation notes that the medication's pharmacological class (thionamides) has been rarely associated with the development of certain autoimmune syndromes. These include a Systemic Lupus Erythematosus (SLE)-like syndrome and vasculitis.

Q: Is it possible to become hypothyroid while taking Tirozol?

Yes, official product warnings state that the medication can cause an underactive thyroid (hypothyroidism). Because of this, thyroid hormone levels must be routinely monitored during the course of treatment to ensure the dosage is appropriate.

How should Tirozol be stored and disposed of?

How to Store and Dispose of Tirozol?

The official storage and disposal requirements for Tirozol (Thiamazole/Methimazole) are defined by regulatory authorities to maintain product stability and ensure environmental safety.


Official Storage Requirements

Condition Regulatory Mandate
Temperature Store at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F).
Packaging Must be kept in a tight and light-resistant container.
Constraint Must not be stored outside this temperature range, which prohibits freezing or excessive heat.

Official Disposal Rules

Official guidance mandates that unused or expired Tirozol should be taken to a drug take-back program or mail-back service. As the medicine is not on the flush list, it must not be flushed down the toilet or poured down the sink. If no take-back option is available, the tablets should be mixed with an undesirable substance, sealed, and thrown into household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tirozol found in:

A-Z Index: